Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


The surprising power of a century-old vaccine for tuberculosis

Written by | 9 Apr 2024

Scientists in Canada believe they may be closer to understanding a positive additional benefit associated with Bacillus Calmette Guérin (BCG), a century-old vaccine for tuberculosis. It turns out… read more.

Submission of phase III study data on pulmonary tuberculosis to the EMA and FDA for Sirturo (bedaquiline) – Janssen Pharma

Written by | 15 Nov 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced the submission of a Type II Variation application to the European Medicines Agency (EMA) for the Company’s medicine… read more.

Nearly half of tuberculosis cases in prisons worldwide go undetected

Written by | 9 Jul 2023

In the first global assessment of TB among incarcerated people, a new study found consistently high TB case rates and low case detection in prisons, suggesting the need… read more.

AI software at least as good as radiologists at detecting TB from chest X-rays

Written by | 22 Apr 2023

AI software can accurately detect TB from chest X-rays, a study being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark,… read more.

Common heartburn drugs could speed up TB treatment

Written by | 10 Feb 2023

The findings, published in Proceedings of the National Academy of Sciences (PNAS) today, may mean TB can be cured with shorter treatments. TB typically takes months to treat with multiple… read more.

New testing method could make tuberculosis diagnosis easier

Written by | 19 Oct 2022

Tuberculosis can be tough to detect. Diagnosis usually requires coughing up a sputum sample from the lungs, which can be unpleasant, impractical, and even hazardous. But in a… read more.

BCG vaccine appears to protect patients with type 1 diabetes from COVID-19 infection

Written by | 23 Aug 2022

Multiple does of the Bacillus Calmette-Guerin (BCG) vaccine appears to offer patients with type 1 diabetes strong protection against COVID-19, researchers reported on August 15, 2022 in Cell… read more.

Discovering new treatments for tuberculosis

Written by | 27 Jul 2022

Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe’s population. Treatment of infections is problematic… read more.

How to make the TB vaccine more effective

Written by | 16 Mar 2022

Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research… read more.

Researchers develop novel strategy for tuberculosis vaccine

Written by | 29 Aug 2021

Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis. Mycobacterium tuberculosis (Mtb)… read more.

Four-month TB therapy proves as effective as 6-month standard regimen

Written by | 24 May 2021

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.